S. Kargman et al., MECHANISM OF SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN G H SYNTHASE-1 AND SYNTHASE-2 IN INTACT-CELLS/, Biochemical pharmacology, 52(7), 1996, pp. 1113-1125
Selective inhibitors of prostaglandin synthase-2 (PGHS-2) possess pote
nt anti-inflammatory, antipyretic, and analgesic properties but demons
trate reduced side-effects (e.g. gastrotoxicity) when compared with no
nselective inhibitors of PGHS-1 and -2. We investigated the mechanism
of the differential inhibition of human PGHS-1 (hPGHS-1) and -2 (hPGHS
-2) in intact cells by nonsteroidal anti-inflammatory drugs (NSAIDs) a
nd examined factors that contribute to the increased potency of PGHS i
nhibitors observed in intact cells versus cell-free systems. In intact
Chinese hamster ovary (CHO) cell lines stably expressing the hPGHS is
ozymes, both PGHS isoforms exhibited the same affinity for arachidonic
acid. Exogenous and endogenous arachidonic acid were used as substrat
es by both CHO [hPGHS-1] and CHO [hPGHS 2] cell lines. However, differ
ences were observed in the ability of the hPGHS isoforms to utilize en
dogenous arachidonic acid released intracellularly following calcium i
onophore stimulation or released by human cytosolic phospholipase A(2)
transiently expressed in the cells. Cell-based screening of PGHS inhi
bitors demonstrated that the selectivities and potencies of PGHS inhib
itors determined using intact cells are affected by substrate concentr
ation and differ from that determined in cell free microsomal or purif
ied enzyme preparations of PGHS isozymes. The mechanism of inhibition
of PGHS isozymes by NSAIDs in intact cells involved a difference in th
eir time-dependent inhibition. Indomethacin displayed time-dependent i
nhibition of cellular hPGHS-1 and -2. In contrast, the selective PGHS-
2 inhibitor NS-398 exhibited time-independent inhibition of hPGHS-1 bu
t time-dependent inhibition of hPGHS-2 in intact cells. Reversible inh
ibition of cellular CHO [hPGHS-1] and CHO [hPGHS-2] was observed with
the nonselective NSAIDs ibuprofen and indomethacin, whereas inhibition
by the selective PGHS 2 inhibitor DuP-697 was reversible against hPGH
S-1 but irreversible against hPGHS-2.